Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET
Company Participants
Joe Rayne - Argot Partners
Richard Paulson - President & Chief Executive Officer
Sohanya Cheng - Senior Vice President-Sales & Commercial Operations
Jatin Shah - Chief Medical Officer
Mike Mason - Chief Financial Officer
Conference Call Participants
Brian Abrams - RBC Capital Markets
Peter Lawson - Barclays
David Lebowitz - Morgan Stanley
Eric Joseph - JPMorgan
Jonathan Chang - SVB Leerink
Colleen Kusy - Baird
Operator
Good morning. My name is Karen, and I will be your conference operator today. At this time, I’d like to welcome everyone to Karyopharm Therapeutics' Second Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advice that this call is being recorded at the company's request.
I would now like to turn the call over to Joe Rayne from Argot Partners. Please go ahead, sir.
Joe Rayne
Thank you, Karen. And thank you all for joining us on today's conference call, to discuss Karyopharm's second quarter financial results and business update. Today, I'm joined by, Mr. Richard Paulson, President and Chief Executive Officer, Ms. Sohanya Cheng, Senior Vice President, Sales and Commercial Operations, Dr. Jatin Shah, Chief Medical Officer, Mr. Mike Mason, Chief Financial Officer; Dr. Sharon Shacham, Chief Scientific Officer; and Mr. Stephen Mitchener, Chief Business Officer.
During today's call, which is outline on slide 2, Richard will provide some introductory remarks, Sohanya will provide an update on our XPOVIO commercial progress, Jatin will highlight recent pipeline advancements, and then Mike will discuss the second quarter financial results highlights. We will conclude with some thoughts from Richard on upcoming milestones, and then we will move to the Q&A portion of the call.
Earlier this morning, we issued a press release, detailing
- Read more current KPTI analysis and news
- View all earnings call transcripts